SMS Pharmaceuticals Ltd has announced the successful completion of a US Food and Drug Administration (USFDA) inspection at its Active Pharmaceutical Ingredient (API) manufacturing facility in ...
SMS Pharmaceuticals Limited (NSE: SMSPHARMA; BSE: 532815) today announced the successful completion of a US Food and Drug Administration (USFDA) inspection at its Active Pharmaceutical Ingredient (API ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback